M
Mario Cioce
Researcher at New York University
Publications - 39
Citations - 2713
Mario Cioce is an academic researcher from New York University. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 18, co-authored 31 publications receiving 2474 citations. Previous affiliations of Mario Cioce include University of Dundee & European Institute of Oncology.
Papers
More filters
Journal ArticleDOI
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
Mark Pearson,Roberta Carbone,Carla Sebastiani,Mario Cioce,Marta Fagioli,Shin'ichi Saito,Yuichiro Higashimoto,Ettore Appella,Saverio Minucci,Pier Paolo Pandolfi,Pier Giuseppe Pelicci,Pier Giuseppe Pelicci +11 more
TL;DR: It is found that oncogenic Ras upregulates PML expression, and overexpression of PML induces senescence in a p53-dependent manner, and integrity of the PML bodies is required for p53 acetylation and senescences upon oncogene expression.
Journal ArticleDOI
Cajal bodies: a long history of discovery.
Mario Cioce,Angus I. Lamond +1 more
TL;DR: This review surveys what is known about the structure and function of the subnuclear domains called Cajal bodies, and considers the interesting links that have emerged between CBs and alterations in nuclear structure apparent in a range of human pathologies.
Journal ArticleDOI
Oligomerization of RAR and AML1 Transcription Factors as a Novel Mechanism of Oncogenic Activation
Saverio Minucci,Marco Maccarana,Mario Cioce,Pasquale De Luca,Vania Gelmetti,Simona Segalla,Luciano Di Croce,Sabrina Giavara,Cristian Matteucci,Alberto Gobbi,Andrea Bianchini,Emanuela Colombo,Ilaria Schiavoni,Ilaria Schiavoni,Gianfranco Badaracco,Xiao Hu,Mitchell A. Lazar,Nicoletta Landsberger,Clara Nervi,Pier Giuseppe Pelicci +19 more
TL;DR: The results show that oligomerization of a transcription factor, imposing an altered interaction with transcriptional coregulators, represents a novel mechanism of oncogenic activation.
Journal ArticleDOI
Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC
Giovanni Blandino,Mariacristina Valerio,Mario Cioce,Federica Mori,Luca Casadei,Claudio Pulito,Andrea Sacconi,Francesca Biagioni,Giancarlo Cortese,Sergio Galanti,Cesare Manetti,Gennaro Citro,Paola Muti,Paola Muti,Sabrina Strano +14 more
TL;DR: It is suggested that DICER modulation, mir33a upregulation and c-MYC targeting have an important role in the anticancer metabolic effects of metformin.
Journal ArticleDOI
SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells
Claudia Canino,Federica Mori,A. M. Cambria,Adamo Diamantini,S. Germoni,Gabriele Alessandrini,G. Borsellino,Rossella Galati,Luca Battistini,R. Blandino,Francesco Facciolo,Gennaro Citro,Sabrina Strano,Paola Muti,Giovanni Blandino,Mario Cioce +15 more
TL;DR: It is shown that pemetrexed-treated mesothelioma cells undergo accelerated senescence, characterized by the secretion of proinflammatory and mitogenic cytokines, reminiscent of an SASP (senescence-associated secretory phenotype), and that small hairpin RNA-mediated ablation of STAT3 deeply attenuates the induction of EMT genes and the increase of ALDHbright cells induced by SASP-cytokines.